Pacira BioSciences CFO Sells 12,941 Shares Ahead of Q1 Earnings Release
Pacira BioSciences' CFO, Shawn Cross, sold 12,941 shares of the company's stock for approximately $326,000 on April 23, 2026, ahead of the Q1 earnings release. The transaction represented 10.94% of his direct holdings at the time and involved the exercise of stock options followed by an immediate sale. The move has raised questions about insider liquidity strategies and potential market implications.
Tickers: $PCRX
Topics: CFO activity insider trading Pacira BioSciences SEC Form 4 stock options